QIAGEN N.V. Boosts Growth with Goldman Sachs Stake & Nordic Single-Cell Sequencing Deal
Goldman Sachs backs QIAGEN as it expands single‑cell sequencing in the Nordics, strengthening its portfolio of sample‑to‑insight solutions and market resilience.
2 minutes to read